Cargando…
Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
Currently there are no FDA approved targeted therapies for Triple Negative Breast Cancer (TNBC). Ongoing clinical trials for TNBC have focused primarily on targeting the epithelial cancer cells. However, targeted delivery of cytotoxic payloads to the non-transformed tumor associated-endothelium can...
Autores principales: | Upreti, Meenakshi, Jyoti, Amar, Johnson, Sara E., Swindell, Elden P., Napier, Dana, Sethi, Pallavi, Chan, Ryan, Feddock, Jonathan M., Weiss, Heidi L., O'Halloran, Thomas V., Mark Evers, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173078/ https://www.ncbi.nlm.nih.gov/pubmed/27223428 http://dx.doi.org/10.18632/oncotarget.9490 |
Ejemplares similares
-
The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target
por: O'Halloran, Thomas V., et al.
Publicado: (2013) -
An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids
por: Jyoti, Amar, et al.
Publicado: (2015) -
Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
por: Johnson, Jeremy, et al.
Publicado: (2020) -
Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023) -
Structural and Mechanistic Basis of Zinc Regulation Across the E. coli Zur Regulon
por: Gilston, Benjamin A., et al.
Publicado: (2014)